baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Regeneron Pharmaceuticals INC REG.../ US75886F1075 /

19/04/2024 00:00:00	Chg. -	Volume	Bid06:00:04	Ask06:00:04	Market Capitalization	Dividend Y.	P/E Ratio
906.38USD	-	320 Turnover: -	-Bid Size: -	-Ask Size: -	114.21 bill.USD	-	27.98

GlobeNewswire 14/06 ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change

GlobeNewswire 14/06 INVESTOR ALERT: Edelson Lechtzin LLP Urges Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Shareholders...

GlobeNewswire 14/06 Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire 14/06 Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivota...

GlobeNewswire 14/06 Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18

GlobeNewswire 14/06 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BATL, DRQ, RPHM, PRFT on Behalf of Sharehol...

GlobeNewswire 14/06 DEADLINE ALERT for MRNS and GRTS: The Law Offices of Frank R. Cruz Reminds Investors of Class Action...

GlobeNewswire 13/06 Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment

GlobeNewswire 12/06 Investment Opportunity: PlantForm Corporation Seeks $25M to Accelerate Plant-Based Medical Breakthro...

GlobeNewswire 11/06 SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emuls...

GlobeNewswire 11/06 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 11/06 60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Pat...

GlobeNewswire 11/06 Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic A...

GlobeNewswire 11/06 NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

GlobeNewswire 11/06 Alvotech and STADA add to strategic alliance through denosumab partnership

GlobeNewswire 11/06 NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

GlobeNewswire 11/06 ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...

GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...

GlobeNewswire 10/06 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...

GlobeNewswire 06/06 BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit

GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...

GlobeNewswire 06/06 Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic For...

GlobeNewswire 06/06 MRNS INVESTOR NEWS: ROSEN, A LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to...

GlobeNewswire 05/06 CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward

GlobeNewswire 05/06 Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at th...

Regeneron Pharmaceuticals INC REG.../ US75886F1075 /

If you wish to receive reply to your feedback, please provide your email address.